BioRestorative Therapies, Inc（BRTX）美股招股说明书 S-1 （2025-11-18首版）（英文版）（31页）.pdf

1、S-1 1 forms-1.htm S-1 As filed with the Securities and Exchange Commission on November 18,2025 Registration No.333-_ UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 FORM S-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933 BIORESTORATIVE THERAPIES,INC.(Exact name of registran

2、t as specified in its charter)Nevada 8099 30-1341024(State or other jurisdiction of(Primary Standard Industrial(I.R.S.Employerincorporation or organization)Classification Code Number)Identification Number)40 Marcus Drive,Suite OneMelville,New York 11747(631)760-8100(Address,including zip code,and te

3、lephone number,including area code,of registrants principal executive offices)Lance Alstodt,President and Chief Executive OfficerBioRestorative Therapies,Inc.40 Marcus Drive,Suite OneMelville,New York 11747(631)760-8100(Name,address,including zip code,and telephone number,including area code,of agen

4、t for service)With a copy to:Fred Skolnik,Esq.Certilman Balin Adler&Hyman,LLP90 Merrick AvenueEast Meadow,New York 11554(516)296-7048 Approximate date of commencement of proposed sale to the public:As soon as practicable after the effective date ofthis registration statement If any of the securities

5、 being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule415 under the Securities Act of 1933,check the following box.If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,pleasecheck the follo

6、wing box and list the Securities Act registration statement number of the earlier effective registration statement forthe same offering.If this Form is a post-effective amendment filed pursuant to Rule 462(c)under the Securities Act,check the following boxand list the Securities Act registration sta